Page last updated: 2024-10-21

vanilmandelic acid and Akinetic-Rigid Variant of Huntington Disease

vanilmandelic acid has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McNamee, B1
Kelvin, AS1
Turnbull, MJ1
Tourian, AY1

Trials

1 trial available for vanilmandelic acid and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Administration of 5-hydroxy-L-tryptophan to individuals with Huntington's chorea.
    Neurology, 1972, Volume: 22, Issue:11

    Topics: 5-Hydroxytryptophan; Adult; Brain; Evaluation Studies as Topic; Female; Humans; Huntington Disease;

1972

Other Studies

1 other study available for vanilmandelic acid and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Urinary excretion of some monoamines and metabolites in Huntington's chorea.
    Scottish medical journal, 1971, Volume: 16, Issue:5

    Topics: Acetates; Adult; Aged; Catecholamines; Epinephrine; Female; Histamine; Humans; Huntington Disease; H

1971